Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GALT | PRLD | RCEL | ||
| Company | Galectin Therapeutic | Prelude Therapeutics Inc | Avita Medical Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.23 | 3.99 | 8.28 | ||
| High | 3.55 | 4.09 | 8.36 | ||
| Low | 3.20 | 3.99 | 8.01 | ||
| Last | 3.50 | 4.04 | 8.30 | ||
| Change | +0.21 | +0.17 | -0.27 | ||
| % Change | +6.38% | +4.39% | -3.15% | ||
| Volume | 212,000 | 115,700 | 251,800 | ||
| 20-Day Average Volume | 309,370 | 46,990 | 345,500 | ||
| Previous Close | 3.29 | 3.87 | 8.57 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.36 | 4.56 | 11.88 | ||
| 20-Day Raw Stochastic | 61.74% | 25.73% | 3.36% | ||
| 20-Day Relative Strength | 60.85% | 45.66% | 22.97% | ||
| Weighted Alpha | +69.53 | -40.21 | -45.63 | ||
| Today's Opinion | 96% Buy | 56% Buy | 40% Sell | ||
| Previous Opinion | 80% Buy | 40% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.55% since 04/18/24 | +17.44% since 04/18/24 | -6.43% since 04/18/24 | ||
| Low | 2.88 on 04/22/24 | 3.45 on 04/19/24 | 8.01 on 04/25/24 | ||
| High | 3.55 on 04/25/24 | 4.13 on 04/24/24 | 9.27 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | +50.21% since 03/25/24 | -12.36% since 03/25/24 | -47.68% since 03/25/24 | ||
| Low | 2.26 on 04/01/24 | 3.42 on 04/18/24 | 8.01 on 04/25/24 | ||
| High | 4.27 on 04/12/24 | 5.83 on 04/15/24 | 16.65 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | +95.53% since 01/25/24 | +20.96% since 01/25/24 | -50.36% since 01/25/24 | ||
| Low | 1.59 on 02/07/24 | 2.62 on 02/09/24 | 8.01 on 04/25/24 | ||
| High | 4.27 on 04/12/24 | 5.83 on 04/15/24 | 18.93 on 02/27/24 | ||
| 6-Month | |||||
| %Chg | +69.90% since 10/25/23 | +95.17% since 10/25/23 | -16.67% since 10/25/23 | ||
| Low | 1.55 on 12/29/23 | 1.66 on 11/01/23 | 8.01 on 04/25/24 | ||
| High | 4.27 on 04/12/24 | 5.83 on 04/15/24 | 18.93 on 02/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 216,664 | 221,881 | 214,140 | ||
| Shares Outstanding, K | 61,904 | 54,921 | 25,800 | ||
| Annual Sales | 0 | 0 | 50,140,000 | ||
| Annual Net Income | -41,070,000 | -121,830,000 | -35,380,000 | ||
| Last Quarter Sales | 0 | 0 | 14,200,000 | ||
| Last Quarter Net Income | -10,000,000 | -33,080,000 | -7,070,000 | ||
| 60-Month Beta | 0.84 | 1.51 | 1.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 03/29/24 | -0.47 on 02/15/24 | -0.28 on 02/22/24 | ||
| Latest Earnings Date | 05/20/24 | 05/13/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||